0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Oncolytic Virus Manufacturing Services Market Research Report 2024
Published Date: June 2024
|
Report Code: QYRE-Auto-33A17307
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Oncolytic Virus Manufacturing Services Market Research Report 2024
BUY CHAPTERS

Global Oncolytic Virus Manufacturing Services Market Research Report 2024

Code: QYRE-Auto-33A17307
Report
June 2024
Pages:90
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Oncolytic Virus Manufacturing Services Market

Oncolytic virus manufacturing services refer to specialized biomanufacturing processes that involve the production of oncolytic viruses, which are viruses engineered or naturally occurring that selectively infect and kill cancer cells. These services encompass a range of activities, from virus design and development to large-scale production and quality control, ensuring that the oncolytic viruses are safe, effective, and meet regulatory standards for clinical and commercial use.
The global Oncolytic Virus Manufacturing Services market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Oncolytic Virus Manufacturing Services is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Oncolytic Virus Manufacturing Services is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Oncolytic Virus Manufacturing Services in R&D is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Oncolytic Virus Manufacturing Services include Recipharm (Vibalogics), IDT Biologika, FUJIFILM Diosynth Biotechnologies, Exothera, Lonza, Creative Biolabs, Takara Bio, Libentech, ABL, Nabios, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Oncolytic Virus Manufacturing Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oncolytic Virus Manufacturing Services.
The Oncolytic Virus Manufacturing Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oncolytic Virus Manufacturing Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oncolytic Virus Manufacturing Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Oncolytic Virus Manufacturing Services Market Report

Report Metric Details
Report Name Oncolytic Virus Manufacturing Services Market
Segment by Type
  • Oncolytic Herpes Simplex Virus
  • Oncolytic Adenovirus
  • Oncolytic Vaccinia Virus
  • Others
Segment by Application
  • R&D
  • Biopharmaceutical Manufacturers
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Recipharm (Vibalogics), IDT Biologika, FUJIFILM Diosynth Biotechnologies, Exothera, Lonza, Creative Biolabs, Takara Bio, Libentech, ABL, Nabios, Halix, Obio Technology, Porton Advanced, WuXi ATU, Genevoyager
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Oncolytic Virus Manufacturing Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Oncolytic Virus Manufacturing Services Market report?

Ans: The main players in the Oncolytic Virus Manufacturing Services Market are Recipharm (Vibalogics), IDT Biologika, FUJIFILM Diosynth Biotechnologies, Exothera, Lonza, Creative Biolabs, Takara Bio, Libentech, ABL, Nabios, Halix, Obio Technology, Porton Advanced, WuXi ATU, Genevoyager

What are the Application segmentation covered in the Oncolytic Virus Manufacturing Services Market report?

Ans: The Applications covered in the Oncolytic Virus Manufacturing Services Market report are R&D, Biopharmaceutical Manufacturers, Others

What are the Type segmentation covered in the Oncolytic Virus Manufacturing Services Market report?

Ans: The Types covered in the Oncolytic Virus Manufacturing Services Market report are Oncolytic Herpes Simplex Virus, Oncolytic Adenovirus, Oncolytic Vaccinia Virus, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oncolytic Virus Manufacturing Services Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Oncolytic Herpes Simplex Virus
1.2.3 Oncolytic Adenovirus
1.2.4 Oncolytic Vaccinia Virus
1.2.5 Others
1.3 Market by Application
1.3.1 Global Oncolytic Virus Manufacturing Services Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 R&D
1.3.3 Biopharmaceutical Manufacturers
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oncolytic Virus Manufacturing Services Market Perspective (2019-2030)
2.2 Global Oncolytic Virus Manufacturing Services Growth Trends by Region
2.2.1 Global Oncolytic Virus Manufacturing Services Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Oncolytic Virus Manufacturing Services Historic Market Size by Region (2019-2024)
2.2.3 Oncolytic Virus Manufacturing Services Forecasted Market Size by Region (2025-2030)
2.3 Oncolytic Virus Manufacturing Services Market Dynamics
2.3.1 Oncolytic Virus Manufacturing Services Industry Trends
2.3.2 Oncolytic Virus Manufacturing Services Market Drivers
2.3.3 Oncolytic Virus Manufacturing Services Market Challenges
2.3.4 Oncolytic Virus Manufacturing Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oncolytic Virus Manufacturing Services Players by Revenue
3.1.1 Global Top Oncolytic Virus Manufacturing Services Players by Revenue (2019-2024)
3.1.2 Global Oncolytic Virus Manufacturing Services Revenue Market Share by Players (2019-2024)
3.2 Global Oncolytic Virus Manufacturing Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Oncolytic Virus Manufacturing Services Revenue
3.4 Global Oncolytic Virus Manufacturing Services Market Concentration Ratio
3.4.1 Global Oncolytic Virus Manufacturing Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oncolytic Virus Manufacturing Services Revenue in 2023
3.5 Global Key Players of Oncolytic Virus Manufacturing Services Head office and Area Served
3.6 Global Key Players of Oncolytic Virus Manufacturing Services, Product and Application
3.7 Global Key Players of Oncolytic Virus Manufacturing Services, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Oncolytic Virus Manufacturing Services Breakdown Data by Type
4.1 Global Oncolytic Virus Manufacturing Services Historic Market Size by Type (2019-2024)
4.2 Global Oncolytic Virus Manufacturing Services Forecasted Market Size by Type (2025-2030)
5 Oncolytic Virus Manufacturing Services Breakdown Data by Application
5.1 Global Oncolytic Virus Manufacturing Services Historic Market Size by Application (2019-2024)
5.2 Global Oncolytic Virus Manufacturing Services Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Oncolytic Virus Manufacturing Services Market Size (2019-2030)
6.2 North America Oncolytic Virus Manufacturing Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Oncolytic Virus Manufacturing Services Market Size by Country (2019-2024)
6.4 North America Oncolytic Virus Manufacturing Services Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Oncolytic Virus Manufacturing Services Market Size (2019-2030)
7.2 Europe Oncolytic Virus Manufacturing Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Oncolytic Virus Manufacturing Services Market Size by Country (2019-2024)
7.4 Europe Oncolytic Virus Manufacturing Services Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Oncolytic Virus Manufacturing Services Market Size (2019-2030)
8.2 Asia-Pacific Oncolytic Virus Manufacturing Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Oncolytic Virus Manufacturing Services Market Size by Region (2019-2024)
8.4 Asia-Pacific Oncolytic Virus Manufacturing Services Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Oncolytic Virus Manufacturing Services Market Size (2019-2030)
9.2 Latin America Oncolytic Virus Manufacturing Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Oncolytic Virus Manufacturing Services Market Size by Country (2019-2024)
9.4 Latin America Oncolytic Virus Manufacturing Services Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oncolytic Virus Manufacturing Services Market Size (2019-2030)
10.2 Middle East & Africa Oncolytic Virus Manufacturing Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Oncolytic Virus Manufacturing Services Market Size by Country (2019-2024)
10.4 Middle East & Africa Oncolytic Virus Manufacturing Services Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Recipharm (Vibalogics)
11.1.1 Recipharm (Vibalogics) Company Details
11.1.2 Recipharm (Vibalogics) Business Overview
11.1.3 Recipharm (Vibalogics) Oncolytic Virus Manufacturing Services Introduction
11.1.4 Recipharm (Vibalogics) Revenue in Oncolytic Virus Manufacturing Services Business (2019-2024)
11.1.5 Recipharm (Vibalogics) Recent Development
11.2 IDT Biologika
11.2.1 IDT Biologika Company Details
11.2.2 IDT Biologika Business Overview
11.2.3 IDT Biologika Oncolytic Virus Manufacturing Services Introduction
11.2.4 IDT Biologika Revenue in Oncolytic Virus Manufacturing Services Business (2019-2024)
11.2.5 IDT Biologika Recent Development
11.3 FUJIFILM Diosynth Biotechnologies
11.3.1 FUJIFILM Diosynth Biotechnologies Company Details
11.3.2 FUJIFILM Diosynth Biotechnologies Business Overview
11.3.3 FUJIFILM Diosynth Biotechnologies Oncolytic Virus Manufacturing Services Introduction
11.3.4 FUJIFILM Diosynth Biotechnologies Revenue in Oncolytic Virus Manufacturing Services Business (2019-2024)
11.3.5 FUJIFILM Diosynth Biotechnologies Recent Development
11.4 Exothera
11.4.1 Exothera Company Details
11.4.2 Exothera Business Overview
11.4.3 Exothera Oncolytic Virus Manufacturing Services Introduction
11.4.4 Exothera Revenue in Oncolytic Virus Manufacturing Services Business (2019-2024)
11.4.5 Exothera Recent Development
11.5 Lonza
11.5.1 Lonza Company Details
11.5.2 Lonza Business Overview
11.5.3 Lonza Oncolytic Virus Manufacturing Services Introduction
11.5.4 Lonza Revenue in Oncolytic Virus Manufacturing Services Business (2019-2024)
11.5.5 Lonza Recent Development
11.6 Creative Biolabs
11.6.1 Creative Biolabs Company Details
11.6.2 Creative Biolabs Business Overview
11.6.3 Creative Biolabs Oncolytic Virus Manufacturing Services Introduction
11.6.4 Creative Biolabs Revenue in Oncolytic Virus Manufacturing Services Business (2019-2024)
11.6.5 Creative Biolabs Recent Development
11.7 Takara Bio
11.7.1 Takara Bio Company Details
11.7.2 Takara Bio Business Overview
11.7.3 Takara Bio Oncolytic Virus Manufacturing Services Introduction
11.7.4 Takara Bio Revenue in Oncolytic Virus Manufacturing Services Business (2019-2024)
11.7.5 Takara Bio Recent Development
11.8 Libentech
11.8.1 Libentech Company Details
11.8.2 Libentech Business Overview
11.8.3 Libentech Oncolytic Virus Manufacturing Services Introduction
11.8.4 Libentech Revenue in Oncolytic Virus Manufacturing Services Business (2019-2024)
11.8.5 Libentech Recent Development
11.9 ABL
11.9.1 ABL Company Details
11.9.2 ABL Business Overview
11.9.3 ABL Oncolytic Virus Manufacturing Services Introduction
11.9.4 ABL Revenue in Oncolytic Virus Manufacturing Services Business (2019-2024)
11.9.5 ABL Recent Development
11.10 Nabios
11.10.1 Nabios Company Details
11.10.2 Nabios Business Overview
11.10.3 Nabios Oncolytic Virus Manufacturing Services Introduction
11.10.4 Nabios Revenue in Oncolytic Virus Manufacturing Services Business (2019-2024)
11.10.5 Nabios Recent Development
11.11 Halix
11.11.1 Halix Company Details
11.11.2 Halix Business Overview
11.11.3 Halix Oncolytic Virus Manufacturing Services Introduction
11.11.4 Halix Revenue in Oncolytic Virus Manufacturing Services Business (2019-2024)
11.11.5 Halix Recent Development
11.12 Obio Technology
11.12.1 Obio Technology Company Details
11.12.2 Obio Technology Business Overview
11.12.3 Obio Technology Oncolytic Virus Manufacturing Services Introduction
11.12.4 Obio Technology Revenue in Oncolytic Virus Manufacturing Services Business (2019-2024)
11.12.5 Obio Technology Recent Development
11.13 Porton Advanced
11.13.1 Porton Advanced Company Details
11.13.2 Porton Advanced Business Overview
11.13.3 Porton Advanced Oncolytic Virus Manufacturing Services Introduction
11.13.4 Porton Advanced Revenue in Oncolytic Virus Manufacturing Services Business (2019-2024)
11.13.5 Porton Advanced Recent Development
11.14 WuXi ATU
11.14.1 WuXi ATU Company Details
11.14.2 WuXi ATU Business Overview
11.14.3 WuXi ATU Oncolytic Virus Manufacturing Services Introduction
11.14.4 WuXi ATU Revenue in Oncolytic Virus Manufacturing Services Business (2019-2024)
11.14.5 WuXi ATU Recent Development
11.15 Genevoyager
11.15.1 Genevoyager Company Details
11.15.2 Genevoyager Business Overview
11.15.3 Genevoyager Oncolytic Virus Manufacturing Services Introduction
11.15.4 Genevoyager Revenue in Oncolytic Virus Manufacturing Services Business (2019-2024)
11.15.5 Genevoyager Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Oncolytic Virus Manufacturing Services Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
 Table 2. Key Players of Oncolytic Herpes Simplex Virus
 Table 3. Key Players of Oncolytic Adenovirus
 Table 4. Key Players of Oncolytic Vaccinia Virus
 Table 5. Key Players of Others
 Table 6. Global Oncolytic Virus Manufacturing Services Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
 Table 7. Global Oncolytic Virus Manufacturing Services Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 8. Global Oncolytic Virus Manufacturing Services Market Size by Region (2019-2024) & (US$ Million)
 Table 9. Global Oncolytic Virus Manufacturing Services Market Share by Region (2019-2024)
 Table 10. Global Oncolytic Virus Manufacturing Services Forecasted Market Size by Region (2025-2030) & (US$ Million)
 Table 11. Global Oncolytic Virus Manufacturing Services Market Share by Region (2025-2030)
 Table 12. Oncolytic Virus Manufacturing Services Market Trends
 Table 13. Oncolytic Virus Manufacturing Services Market Drivers
 Table 14. Oncolytic Virus Manufacturing Services Market Challenges
 Table 15. Oncolytic Virus Manufacturing Services Market Restraints
 Table 16. Global Oncolytic Virus Manufacturing Services Revenue by Players (2019-2024) & (US$ Million)
 Table 17. Global Oncolytic Virus Manufacturing Services Market Share by Players (2019-2024)
 Table 18. Global Top Oncolytic Virus Manufacturing Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncolytic Virus Manufacturing Services as of 2023)
 Table 19. Ranking of Global Top Oncolytic Virus Manufacturing Services Companies by Revenue (US$ Million) in 2023
 Table 20. Global 5 Largest Players Market Share by Oncolytic Virus Manufacturing Services Revenue (CR5 and HHI) & (2019-2024)
 Table 21. Global Key Players of Oncolytic Virus Manufacturing Services, Headquarters and Area Served
 Table 22. Global Key Players of Oncolytic Virus Manufacturing Services, Product and Application
 Table 23. Global Key Players of Oncolytic Virus Manufacturing Services, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Oncolytic Virus Manufacturing Services Market Size by Type (2019-2024) & (US$ Million)
 Table 26. Global Oncolytic Virus Manufacturing Services Revenue Market Share by Type (2019-2024)
 Table 27. Global Oncolytic Virus Manufacturing Services Forecasted Market Size by Type (2025-2030) & (US$ Million)
 Table 28. Global Oncolytic Virus Manufacturing Services Revenue Market Share by Type (2025-2030)
 Table 29. Global Oncolytic Virus Manufacturing Services Market Size by Application (2019-2024) & (US$ Million)
 Table 30. Global Oncolytic Virus Manufacturing Services Revenue Market Share by Application (2019-2024)
 Table 31. Global Oncolytic Virus Manufacturing Services Forecasted Market Size by Application (2025-2030) & (US$ Million)
 Table 32. Global Oncolytic Virus Manufacturing Services Revenue Market Share by Application (2025-2030)
 Table 33. North America Oncolytic Virus Manufacturing Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 34. North America Oncolytic Virus Manufacturing Services Market Size by Country (2019-2024) & (US$ Million)
 Table 35. North America Oncolytic Virus Manufacturing Services Market Size by Country (2025-2030) & (US$ Million)
 Table 36. Europe Oncolytic Virus Manufacturing Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 37. Europe Oncolytic Virus Manufacturing Services Market Size by Country (2019-2024) & (US$ Million)
 Table 38. Europe Oncolytic Virus Manufacturing Services Market Size by Country (2025-2030) & (US$ Million)
 Table 39. Asia-Pacific Oncolytic Virus Manufacturing Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 40. Asia-Pacific Oncolytic Virus Manufacturing Services Market Size by Region (2019-2024) & (US$ Million)
 Table 41. Asia-Pacific Oncolytic Virus Manufacturing Services Market Size by Region (2025-2030) & (US$ Million)
 Table 42. Latin America Oncolytic Virus Manufacturing Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 43. Latin America Oncolytic Virus Manufacturing Services Market Size by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Oncolytic Virus Manufacturing Services Market Size by Country (2025-2030) & (US$ Million)
 Table 45. Middle East & Africa Oncolytic Virus Manufacturing Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 46. Middle East & Africa Oncolytic Virus Manufacturing Services Market Size by Country (2019-2024) & (US$ Million)
 Table 47. Middle East & Africa Oncolytic Virus Manufacturing Services Market Size by Country (2025-2030) & (US$ Million)
 Table 48. Recipharm (Vibalogics) Company Details
 Table 49. Recipharm (Vibalogics) Business Overview
 Table 50. Recipharm (Vibalogics) Oncolytic Virus Manufacturing Services Product
 Table 51. Recipharm (Vibalogics) Revenue in Oncolytic Virus Manufacturing Services Business (2019-2024) & (US$ Million)
 Table 52. Recipharm (Vibalogics) Recent Development
 Table 53. IDT Biologika Company Details
 Table 54. IDT Biologika Business Overview
 Table 55. IDT Biologika Oncolytic Virus Manufacturing Services Product
 Table 56. IDT Biologika Revenue in Oncolytic Virus Manufacturing Services Business (2019-2024) & (US$ Million)
 Table 57. IDT Biologika Recent Development
 Table 58. FUJIFILM Diosynth Biotechnologies Company Details
 Table 59. FUJIFILM Diosynth Biotechnologies Business Overview
 Table 60. FUJIFILM Diosynth Biotechnologies Oncolytic Virus Manufacturing Services Product
 Table 61. FUJIFILM Diosynth Biotechnologies Revenue in Oncolytic Virus Manufacturing Services Business (2019-2024) & (US$ Million)
 Table 62. FUJIFILM Diosynth Biotechnologies Recent Development
 Table 63. Exothera Company Details
 Table 64. Exothera Business Overview
 Table 65. Exothera Oncolytic Virus Manufacturing Services Product
 Table 66. Exothera Revenue in Oncolytic Virus Manufacturing Services Business (2019-2024) & (US$ Million)
 Table 67. Exothera Recent Development
 Table 68. Lonza Company Details
 Table 69. Lonza Business Overview
 Table 70. Lonza Oncolytic Virus Manufacturing Services Product
 Table 71. Lonza Revenue in Oncolytic Virus Manufacturing Services Business (2019-2024) & (US$ Million)
 Table 72. Lonza Recent Development
 Table 73. Creative Biolabs Company Details
 Table 74. Creative Biolabs Business Overview
 Table 75. Creative Biolabs Oncolytic Virus Manufacturing Services Product
 Table 76. Creative Biolabs Revenue in Oncolytic Virus Manufacturing Services Business (2019-2024) & (US$ Million)
 Table 77. Creative Biolabs Recent Development
 Table 78. Takara Bio Company Details
 Table 79. Takara Bio Business Overview
 Table 80. Takara Bio Oncolytic Virus Manufacturing Services Product
 Table 81. Takara Bio Revenue in Oncolytic Virus Manufacturing Services Business (2019-2024) & (US$ Million)
 Table 82. Takara Bio Recent Development
 Table 83. Libentech Company Details
 Table 84. Libentech Business Overview
 Table 85. Libentech Oncolytic Virus Manufacturing Services Product
 Table 86. Libentech Revenue in Oncolytic Virus Manufacturing Services Business (2019-2024) & (US$ Million)
 Table 87. Libentech Recent Development
 Table 88. ABL Company Details
 Table 89. ABL Business Overview
 Table 90. ABL Oncolytic Virus Manufacturing Services Product
 Table 91. ABL Revenue in Oncolytic Virus Manufacturing Services Business (2019-2024) & (US$ Million)
 Table 92. ABL Recent Development
 Table 93. Nabios Company Details
 Table 94. Nabios Business Overview
 Table 95. Nabios Oncolytic Virus Manufacturing Services Product
 Table 96. Nabios Revenue in Oncolytic Virus Manufacturing Services Business (2019-2024) & (US$ Million)
 Table 97. Nabios Recent Development
 Table 98. Halix Company Details
 Table 99. Halix Business Overview
 Table 100. Halix Oncolytic Virus Manufacturing Services Product
 Table 101. Halix Revenue in Oncolytic Virus Manufacturing Services Business (2019-2024) & (US$ Million)
 Table 102. Halix Recent Development
 Table 103. Obio Technology Company Details
 Table 104. Obio Technology Business Overview
 Table 105. Obio Technology Oncolytic Virus Manufacturing Services Product
 Table 106. Obio Technology Revenue in Oncolytic Virus Manufacturing Services Business (2019-2024) & (US$ Million)
 Table 107. Obio Technology Recent Development
 Table 108. Porton Advanced Company Details
 Table 109. Porton Advanced Business Overview
 Table 110. Porton Advanced Oncolytic Virus Manufacturing Services Product
 Table 111. Porton Advanced Revenue in Oncolytic Virus Manufacturing Services Business (2019-2024) & (US$ Million)
 Table 112. Porton Advanced Recent Development
 Table 113. WuXi ATU Company Details
 Table 114. WuXi ATU Business Overview
 Table 115. WuXi ATU Oncolytic Virus Manufacturing Services Product
 Table 116. WuXi ATU Revenue in Oncolytic Virus Manufacturing Services Business (2019-2024) & (US$ Million)
 Table 117. WuXi ATU Recent Development
 Table 118. Genevoyager Company Details
 Table 119. Genevoyager Business Overview
 Table 120. Genevoyager Oncolytic Virus Manufacturing Services Product
 Table 121. Genevoyager Revenue in Oncolytic Virus Manufacturing Services Business (2019-2024) & (US$ Million)
 Table 122. Genevoyager Recent Development
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Oncolytic Virus Manufacturing Services Picture
 Figure 2. Global Oncolytic Virus Manufacturing Services Market Size Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Oncolytic Virus Manufacturing Services Market Share by Type: 2023 VS 2030
 Figure 4. Oncolytic Herpes Simplex Virus Features
 Figure 5. Oncolytic Adenovirus Features
 Figure 6. Oncolytic Vaccinia Virus Features
 Figure 7. Others Features
 Figure 8. Global Oncolytic Virus Manufacturing Services Market Size by Application (2024-2030) & (US$ Million)
 Figure 9. Global Oncolytic Virus Manufacturing Services Market Share by Application: 2023 VS 2030
 Figure 10. R&D Case Studies
 Figure 11. Biopharmaceutical Manufacturers Case Studies
 Figure 12. Others Case Studies
 Figure 13. Oncolytic Virus Manufacturing Services Report Years Considered
 Figure 14. Global Oncolytic Virus Manufacturing Services Market Size (US$ Million), Year-over-Year: 2019-2030
 Figure 15. Global Oncolytic Virus Manufacturing Services Market Size, (US$ Million), 2019 VS 2023 VS 2030
 Figure 16. Global Oncolytic Virus Manufacturing Services Market Share by Region: 2023 VS 2030
 Figure 17. Global Oncolytic Virus Manufacturing Services Market Share by Players in 2023
 Figure 18. Global Top Oncolytic Virus Manufacturing Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncolytic Virus Manufacturing Services as of 2023)
 Figure 19. The Top 10 and 5 Players Market Share by Oncolytic Virus Manufacturing Services Revenue in 2023
 Figure 20. North America Oncolytic Virus Manufacturing Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 21. North America Oncolytic Virus Manufacturing Services Market Share by Country (2019-2030)
 Figure 22. United States Oncolytic Virus Manufacturing Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 23. Canada Oncolytic Virus Manufacturing Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 24. Europe Oncolytic Virus Manufacturing Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 25. Europe Oncolytic Virus Manufacturing Services Market Share by Country (2019-2030)
 Figure 26. Germany Oncolytic Virus Manufacturing Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 27. France Oncolytic Virus Manufacturing Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 28. U.K. Oncolytic Virus Manufacturing Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 29. Italy Oncolytic Virus Manufacturing Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 30. Russia Oncolytic Virus Manufacturing Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 31. Nordic Countries Oncolytic Virus Manufacturing Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 32. Asia-Pacific Oncolytic Virus Manufacturing Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 33. Asia-Pacific Oncolytic Virus Manufacturing Services Market Share by Region (2019-2030)
 Figure 34. China Oncolytic Virus Manufacturing Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 35. Japan Oncolytic Virus Manufacturing Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 36. South Korea Oncolytic Virus Manufacturing Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 37. Southeast Asia Oncolytic Virus Manufacturing Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 38. India Oncolytic Virus Manufacturing Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 39. Australia Oncolytic Virus Manufacturing Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 40. Latin America Oncolytic Virus Manufacturing Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 41. Latin America Oncolytic Virus Manufacturing Services Market Share by Country (2019-2030)
 Figure 42. Mexico Oncolytic Virus Manufacturing Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 43. Brazil Oncolytic Virus Manufacturing Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 44. Middle East & Africa Oncolytic Virus Manufacturing Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 45. Middle East & Africa Oncolytic Virus Manufacturing Services Market Share by Country (2019-2030)
 Figure 46. Turkey Oncolytic Virus Manufacturing Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 47. Saudi Arabia Oncolytic Virus Manufacturing Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 48. UAE Oncolytic Virus Manufacturing Services Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 49. Recipharm (Vibalogics) Revenue Growth Rate in Oncolytic Virus Manufacturing Services Business (2019-2024)
 Figure 50. IDT Biologika Revenue Growth Rate in Oncolytic Virus Manufacturing Services Business (2019-2024)
 Figure 51. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Oncolytic Virus Manufacturing Services Business (2019-2024)
 Figure 52. Exothera Revenue Growth Rate in Oncolytic Virus Manufacturing Services Business (2019-2024)
 Figure 53. Lonza Revenue Growth Rate in Oncolytic Virus Manufacturing Services Business (2019-2024)
 Figure 54. Creative Biolabs Revenue Growth Rate in Oncolytic Virus Manufacturing Services Business (2019-2024)
 Figure 55. Takara Bio Revenue Growth Rate in Oncolytic Virus Manufacturing Services Business (2019-2024)
 Figure 56. Libentech Revenue Growth Rate in Oncolytic Virus Manufacturing Services Business (2019-2024)
 Figure 57. ABL Revenue Growth Rate in Oncolytic Virus Manufacturing Services Business (2019-2024)
 Figure 58. Nabios Revenue Growth Rate in Oncolytic Virus Manufacturing Services Business (2019-2024)
 Figure 59. Halix Revenue Growth Rate in Oncolytic Virus Manufacturing Services Business (2019-2024)
 Figure 60. Obio Technology Revenue Growth Rate in Oncolytic Virus Manufacturing Services Business (2019-2024)
 Figure 61. Porton Advanced Revenue Growth Rate in Oncolytic Virus Manufacturing Services Business (2019-2024)
 Figure 62. WuXi ATU Revenue Growth Rate in Oncolytic Virus Manufacturing Services Business (2019-2024)
 Figure 63. Genevoyager Revenue Growth Rate in Oncolytic Virus Manufacturing Services Business (2019-2024)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart